Chemistry As A Life Science
A North Jersey Institution
A North Jersey Institution
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| Chemistry As A Life Science Symposium (CLSS) is held under the auspices of the ACS through the Divisions of Medicinal and Organic Chemistry and the North Jersey Section. The meeting, which attracts 600-800 scientists, is hosted by Rutgers University. It is sponsored by almost 20 research based chemical companies and is organized by a committee drawn from many of the biggest pharmaceutical companies in New Jersey. I have served on the organizing committee on three occasions. The meeting continues to focus on the chemistry and biology interface as chemistry itself continues to move to become an inclusive science – one that incorporates all of the various disciplines to which it contributes, especially the biological sciences. |
| The speakers at one of The Chemistry as a Life Science Symposia I helped organize |
| The lunch at the Chemistry as a Life Science Symposium |
| Dinner with the organizing committee and speakers |
| Links |
| Each year while many of the ~600-800 attendees visit Newark restaurants for lunch ~150 are invited to lunch with the speakers at Rutgers |
Chemistry as a Life Science
A Historical Perspective
This biennial, one-day symposia is held under the auspices of the American Chemical Society through its
Division of Medicinal Chemistry, Division of Organic Chemistry and its North Jersey Section, and sponsored by
more than a score of major pharmaceutical and related research-based chemical companies.
The series began in 1982 with a symposium dedicated to the memory of Dr. Willy Leimgruber, an organic
chemist and Director of Chemical Research at Hoffmann-La Roche in Nutley from 1973 until his death in 1981.
His research interests had included structure elucidation and synthesis of natural products and the study of
their potential utility as medicinal agents. As with all the ensuing symposia, the first symposium was an
overwhelming success, attracting a capacity audience of over 750 research chemists from academia and
industry.
It became immediately clear after the initial event that such a symposium, in the heartland of the
pharmaceutical industry, had served a scientific need of the research-based chemical and pharmaceutical
community in New Jersey and the Eastern Seaboard's middle-Atlantic region. Subsequently, key
representatives from the pharmaceutical research industry in northern New Jersey solidified the organizational
process to insure that similar events would continue into the future on a biennial basis.
Invitational lectures at the pioneering symposium addressed issues central to the focus of modern
pharmaceutical research, ranging from synthetic organic chemistry to topics at the interface of chemistry and
biology. Subsequent meetings have adopted this philosophy and format, continuing to focus the attention of
research chemists on the relevance of their science to an understanding of biology at the molecular level and
to the ability of organic chemists to intervene in biological processes for therapeutic benefits.
Rutgers, the State University, was the host organization and provided the use of the Newark campus facilities
with the compliments of the State of New Jersey. Financial support, which has always made this series
possible, was once again generously provided by most of the major pharmaceutical companies and related
chemical companies on the Eastern Seaboard.
A Historical Perspective
This biennial, one-day symposia is held under the auspices of the American Chemical Society through its
Division of Medicinal Chemistry, Division of Organic Chemistry and its North Jersey Section, and sponsored by
more than a score of major pharmaceutical and related research-based chemical companies.
The series began in 1982 with a symposium dedicated to the memory of Dr. Willy Leimgruber, an organic
chemist and Director of Chemical Research at Hoffmann-La Roche in Nutley from 1973 until his death in 1981.
His research interests had included structure elucidation and synthesis of natural products and the study of
their potential utility as medicinal agents. As with all the ensuing symposia, the first symposium was an
overwhelming success, attracting a capacity audience of over 750 research chemists from academia and
industry.
It became immediately clear after the initial event that such a symposium, in the heartland of the
pharmaceutical industry, had served a scientific need of the research-based chemical and pharmaceutical
community in New Jersey and the Eastern Seaboard's middle-Atlantic region. Subsequently, key
representatives from the pharmaceutical research industry in northern New Jersey solidified the organizational
process to insure that similar events would continue into the future on a biennial basis.
Invitational lectures at the pioneering symposium addressed issues central to the focus of modern
pharmaceutical research, ranging from synthetic organic chemistry to topics at the interface of chemistry and
biology. Subsequent meetings have adopted this philosophy and format, continuing to focus the attention of
research chemists on the relevance of their science to an understanding of biology at the molecular level and
to the ability of organic chemists to intervene in biological processes for therapeutic benefits.
Rutgers, the State University, was the host organization and provided the use of the Newark campus facilities
with the compliments of the State of New Jersey. Financial support, which has always made this series
possible, was once again generously provided by most of the major pharmaceutical companies and related
chemical companies on the Eastern Seaboard.